Harry LeVine, III, PhD
Harry LeVine, III, received his bachelor’s degree in biochemistry from Cornell University and his PhD in Physiological Chemistry from the Johns Hopkins University School of Medicine. He then spent 28 years in the pharmaceutical industry doing basic research and drug discovery at Burroughs Wellcome, Glaxo, Parke-Davis, and Pfizer while serving as adjunct faculty at Duke University and the University of Michigan. In January 2003, he joined the University of Kentucky Sanders-Brown Center on Aging as an associate professor of molecular and cellular biochemistry in the College of Medicine. He teaches and does research on chronic neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s, and Huntington’s. In 2012, he was a Fulbright Scholar at Linkӧping University in Sweden. Dr. LeVine is author of over 140 scientific publications, several books, and three issued U.S. patents. He serves on numerous review panels including the Basic Pharmacology Advisory Committee of the Pharmaceutical Research and Manufacturer’s Association Foundation (PhRMA), which funds early-stage training of students and faculty in pharmacology. He consults for several biotechnology companies in the United States and abroad.